Viewing nowGlimepiride Tablets 4 mg (Glimepiride)
Glimepiride 4mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 200605448 · Notified 2006.06.20 · Insurance code 643500130
Improvement of blood glucose control in type 2 diabetes
This medication is used along with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be administered alone, but if blood sugar control is insufficient, it can be combined with other hypoglycemic agents or insulin. For patients who have insufficient effectiveness with sulfonylureas or monotherapy with metformin, it is given alongside metformin to improve blood sugar control. This approach effectively enhances blood glucose management in patients with type 2 diabetes.
Adjust individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, little additional benefit is seen with doses above 4 mg, but some patients have achieved better metabolic control with increases to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no precise dose-equivalence relationship between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial Dose. That is, initiate treatment with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered drug should be taken into account. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this drug, and regular measurement of glycosylated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose must be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this drug is administered in combination with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes mellitus or those in diabetic ketoacidosis or coma. Additionally, it should not be administered to patients allergic to this medication or its components, including sulfonylureas. Patients with lactose intolerance or certain genetic metabolic disorders should also avoid use. It is not recommended for patients with severe liver or kidney impairment, and women who are pregnant or may become pregnant, or are breastfeeding, should not use this medication. Patients with severe infections, pre- and post-surgery, or severe trauma may require insulin therapy. Patients with gastrointestinal disorders that affect food absorption should use caution due to the risk of hypoglycemia. During the initial dosing, the risk of hypoglycemia is high, so blood glucose levels should be monitored carefully. Elderly patients, those with poor nutritional status or irregular eating patterns, those with an imbalance of exercise and meal timing, and those who frequently consume alcohol are at greater risk for hypoglycemia. Caution is also necessary for patients with impaired liver or kidney function or who are taking other medications. Patients with these risk factors should inform their physician or pharmacist in advance, and dosage adjustments or changes in administration methods may be required. This medication can cause hypoglycemia, and symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, confusion, drowsiness, or loss of consciousness. Visual disturbances, gastrointestinal disturbances, liver function abnormalities, blood abnormalities, and allergic reactions have been reported; if any adverse symptoms occur, immediate consultation with a physician is necessary. Severe allergic reactions or severe hypoglycemia can be life-threatening and require urgent intervention. This medication should be taken in conjunction with dietary and exercise therapy to assist in blood sugar control, and consuming sugar during episodes of hypoglycemia typically leads to rapid recovery. Blood sugar and liver and kidney function should be regularly monitored during treatment, and consultation with a physician is necessary when discontinuing or changing medication. When taken with other medications, blood sugar control may be affected, so it is essential to disclose any medications being taken. Caution is advised, particularly with specific antibiotics, anticoagulants, steroids, beta-blockers, and alcohol, as these can alter the effectiveness of this medication. Pregnant or breastfeeding women are advised to consider insulin therapy instead, as it may affect the fetus or newborn. The safety in children under 18 has not been established, and elderly patients may require dosage adjustments due to decreased kidney function. In case of overdose, severe hypoglycemia may occur, necessitating immediate medical attention and treatment. If symptoms of hypoglycemia appear, rapid sugar intake or assistance from healthcare professionals is needed. This medication should be kept out of reach of children and stored in its original container for safety.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbance, anxiety, aggression, decreased concentration, reduced agility or motivation, depression, confusion, speech abnormality, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and damp skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, biliary secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disorder, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain its efficacy for a longer period.
Pale blue oval-shaped tablet
30 tablets/box [10 tablets/PTPX3], 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.